Literature DB >> 19469750

Ciprofloxacin-induced torsades de pointes in a methadone-dependent patient.

Murali K Nair1, Krunal Patel, Perry J Starer.   

Abstract

ABSTRACT Background Methadone has been associated with QT prolongation and Torsades de pointes. Ciprofloxacin may prolong QT interval and induce Torsades de pointes when other risk factors are present. Case description A case is described in which a patient receiving methadone treatment developed Torsades de pointes following the addition of ciprofloxacin. Conclusion Ciprofloxacin should be used with caution in patients receiving methadone.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19469750     DOI： 10.1111/j.1360-0443.2008.02390.x

Source DB:  PubMed          Journal:  Addiction        ISSN： 0965-2140            Impact factor:   6.526


  5 in total

1.  Interaction between Methadone and Ciprofloxacin.

Authors:  Leslie Samoy; Karen F Shalansky
Journal:  Can J Hosp Pharm       Date:  2010-09

2.  Methadone, QTc interval prolongation and torsade de pointes: Case reports offer the best understanding of this problem.

Authors:  W Victor R Vieweg; Mehrul Hasnain; Robert H Howland; Thomas Clausen; Jayanthi N Koneru; Christopher Kogut; Ericka L Breden Crouse; Jules C Hancox; Antony Fernandez; Ananda K Pandurangi
Journal:  Ther Adv Psychopharmacol       Date:  2013-08

Review 3.  A systematic review of the cardiotoxicity of methadone.

Authors:  Samira Alinejad; Toba Kazemi; Nasim Zamani; Robert S Hoffman; Omid Mehrpour
Journal:  EXCLI J       Date:  2015-05-05       Impact factor: 4.068

4.  Association of oral ciprofloxacin, levofloxacin, ofloxacin and moxifloxacin with the risk of serious ventricular arrhythmia: a nationwide cohort study in Korea.

Authors:  Yongil Cho; Hyun Soo Park
Journal:  BMJ Open       Date:  2018-09-28       Impact factor: 2.692

5.  Pharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycines, macrolides, fluoroquinolones, and Beta-lactams.

Authors:  Mathieu S Bolhuis; Prashant N Panday; Arianna D Pranger; Jos G W Kosterink; Jan-Willem C Alffenaar
Journal:  Pharmaceutics       Date:  2011-11-18       Impact factor: 6.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.